Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11287422 Multivalent binding composition for nucleic acid analysis
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
June 24, 2021
Date of Patent
March 29, 2022
Patent Application Number
17356929
Patent Citations
US Patent 10300452 Methods and compositions for single molecule composition loading
US Patent 10787573 Multimeric protected fluorescent reagents
US Patent 10876148 De novo surface preparation and uses thereof
US Patent 10919033 Flow cells with hydrogel coating
US Patent 10982280 Multipart reagents having increased avidity for polymerase binding
US Patent 11053540 High performance fluorescence imaging module for genomic testing assay
US Patent 11060138 Nucleic acid sequencing systems
US Patent 11118214 Hybridization compositions and methods
US Patent 11118220 Method and apparatus for volumetric imaging of a three-dimensional nucleic acid containing matrix
US Patent 11198121 Flow cell systems and devices
•••
Patent Citations Received
US Patent 11781185 Methods and reagents for nucleic acid analysis
US Patent 12091657 Reverse transcriptase for nucleic acid sequencing
0
US Patent 12134766 Methods for generating circular nucleic acid molecules
0
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11287422
Patent Primary Examiner
Jezia Riley
CPC Code
G01N 33/5308
G01N 33/582
C12Q 1/6874
C12Q 1/6869
Find more entities like US Patent 11287422 Multivalent binding composition for nucleic acid analysis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE